Taken together, these results suggest that, possibly, inhibition of the four core targets (TNF, IL-10, TGF-1, and EGF) and FOXO and MAPK signaling pathways by the compound of Danshen tablets could result in reversal effects on hepatic fibrosis. The gene discussed is TNF; the disease is Hepatic fibrosis.